https://news.augustaheadlines.com/story/472786/refractory-angina-pipeline-and-clinical-trials-assessment-2024-fda-approvals-therapies-and-key-companies-involved-by-delveinsight-cellpraxis-bioengenharia-angionetics-xylocor-therapeutics.html 2024-06-06T10:38:07+00:00 daily 1.0 https://news.augustaheadlines.com/story/472785/inspiring-cancer-therapy-alfa-cytology-unveils-breast-cancer-model-construction-services.html 2024-06-06T10:26:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/472784/jeff-cowan-author-of-what-ive-learned-from-attending-over-40-indy-500s-wins-top-prize-in-international-book-awards-contest.html 2024-06-06T10:20:11+00:00 daily 1.0 https://news.augustaheadlines.com/story/472783/5-fires-teams-up-with-kevin-rudolf-the-inspirational-journey-of-brendon-brady.html 2024-06-06T10:12:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/472782/westborough-ma-real-estate-agent-mark-kosa-celebrates-3-years-as-a-power-agent.html 2024-06-06T10:06:06+00:00 daily 1.0 https://news.augustaheadlines.com/story/472781/myelofibrosis-pipeline-assessment-2024-updates-fda-ema-and-pmda-approvals-emerging-drugs-clinical-trials-therapeutic-analysis-and-growth-prospects-lynk-pharma-samus-therapeutics-taiga.html 2024-06-06T10:00:10+00:00 daily 1.0 https://news.augustaheadlines.com/story/472780/artificial-intelligence-ai-in-healthcare-market-set-for-382-cagr-surge-reaching-usd-25911-billion-by-2031-skyquest-technology.html 2024-06-06T09:56:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/472779/ctla4-inhibitors-market-to-witness-upsurge-in-growth-during-the-study-period-20202034-assesses-delveinsight-molecular-templates-shanghai-henlius-biotech-harbour-biomed-alpine-immune-sciences.html 2024-06-06T09:30:06+00:00 daily 1.0 https://news.augustaheadlines.com/story/472778/automotive-iot-market-to-surpass-usd-63548-billion-by-2031-witnessing-225-cagr-growth.html 2024-06-06T09:26:08+00:00 daily 1.0 https://news.augustaheadlines.com/story/472776/hemophilia-b-market-is-expected-to-showcase-a-significant-growth-during-the-forecast-period-uniqure-biopharma-csl-behring-pfizer-spark-therapeutics-genzyme-novo-nordisk-pfizer-alnylam-pharma.html 2024-06-06T09:08:05+00:00 daily 1.0